Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
This article was originally published in The Tan Sheet
Executive Summary
Aspirin was associated with a 44%-70% reduction in major adverse events when taken within 48 hours of coronary-artery bypass surgery, according to a study in the Oct. 24 New England Journal of Medicine
You may also be interested in...
Low-Dose Aspirin Safety, CVD Efficacy “Superior” To Higher Doses – McNeil
Low-dose aspirin in the range of 81 mg-162 mg has a superior bleeding profile and similar efficacy to higher OTC doses for cardiovascular protection, Eric Topol, MD, Cleveland Clinic Foundation, told the FDA's Nonprescription Drugs Advisory Committee
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands